initial public offering (ipo)

Azelis Raises €1.7 Billion in Brussels IPO

Belgian-headquartered multinational distributor Azelis and its shareholders have raised €1.77 billion in an initial public offering (IPO) on the Euronext Brussels exchange. Azelis gets €880 million from the offering, while shareholders including private equity firm EQT and PSP Investments receive €891 million.

News

Bayer Said to Have Tapped Rothschild for BMS Float

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

WuXi AppTec

Europe’s Biotech Inflection Point

Dow Chemical Company

Anchored in Sustainability

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Sasol

Leading Transformation

Easyfairs Deutschland GmbH

Leading the way. Driving results.

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Easyfairs Deutschland GmbH

Industry Kick-Off with Signal Effect: More Than 310 Exhibitors expected at maintenance and PUMPS & VALVES 2026

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Together for Sustanability (TFS)

Driving Sustainability Through Collaboration

Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.